Cardiology
Heart Failure Outcomes Most Certain With SGLT2 Inhibitors
Across randomized heart-failure trials, SGLT2 inhibitors most reliably reduce worsening heart failure and cardiovascular death. Evidence for lower all-cause mortality is less secure.
Rayan Salih · September 21, 2026 · 7 min